VIELA BIO, INC. General and Administrative Expense
VIELA BIO, INC. reported General and Administrative Expense of $14.41 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2020-08-12
- VIELA BIO, INC. general and administrative expense for the quarter ending 2020-06-30 was $14.41M, a 54.99% increase year-over-year.
- VIELA BIO, INC. general and administrative expense for the quarter ending 2020-03-31 was $15.28M, a 203.39% increase year-over-year.
- VIELA BIO, INC. general and administrative expense for the quarter ending 2019-12-31 was $10.47M, a 383.61% increase year-over-year.
- VIELA BIO, INC. general and administrative expense for the quarter ending 2019-09-30 was $10.23M, a 326.07% increase year-over-year.
- VIELA BIO, INC. general and administrative expense for fiscal 2019 was $35.05M, a 433.89% increase from fiscal 2018.
- VIELA BIO, INC. general and administrative expense for fiscal 2018 was $6.57M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2020-06-30 | $14.41M 10-Q · filed 2020-08-12 | $29.69M 10-Q · filed 2020-08-12 | $40.16M derived: sum of 3 quarters · filed 2020-08-12 | $50.40M derived: sum of 4 quarters · filed 2020-08-12 |
| 2020-03-31 | $15.28M 10-Q · filed 2020-05-13 | $25.76M derived: sum of 2 quarters · filed 2020-05-13 | $35.99M derived: sum of 3 quarters · filed 2020-05-13 | $45.28M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-12-31 | $10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $20.70M derived: sum of 2 quarters · filed 2020-03-25 | $30.00M derived: sum of 3 quarters · filed 2020-08-12 | $35.05M 10-K · filed 2020-03-25 |
| 2019-09-30 | $10.23M 10-Q · filed 2019-11-14 | $19.53M derived: sum of 2 quarters · filed 2020-08-12 | $24.57M 10-Q · filed 2019-11-14 | $26.73M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-06-30 | $9.30M 10-Q · filed 2020-08-12 | $14.33M 10-Q · filed 2020-08-12 | $16.50M derived: sum of 3 quarters · filed 2020-08-12 | $18.90M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $5.04M 10-Q · filed 2020-05-13 | $7.20M derived: sum of 2 quarters · filed 2020-05-13 | $9.60M derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $4.57M derived: sum of 2 quarters · filed 2020-03-25 | $6.57M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $2.40M 10-Q · filed 2019-11-14 | $4.40M 10-Q · filed 2019-11-14 |